Public opinion on the realization of the preference for new drugs developed in Korea is rising ahead of the announcement of the results of research services on drug prices support policies for innovative pharmaceutical companies in line with the international trade order.

The research service, which took place for five months from December last year to this month, is handled by Professor Park Mi-hye of Sungkyunkwan University with the order of the KHIDI, and is scheduled to be published as a report in June and July.

The background of the research is due to the feasibility review of the MOHW's written inquiry of last year's parliamentary audit in the absence of subordinate laws due to trad